TGFBI (182 aa), Recombinant protein, 10 ug.
- Known as:
- TGFBI (182 aa), Recombinant protein, 10 ug.
- Catalog number:
- PR27154-10
- Product Quantity:
- 1
- Category:
- -
- Supplier:
- Neuromi
- Gene target:
- TGFBI (182 ) Recombinant protein 10 .
Related genes to: TGFBI (182 aa), Recombinant protein, 10 ug.
- Gene:
- ABCC10 NIH gene
- Name:
- ATP binding cassette subfamily C member 10
- Previous symbol:
- -
- Synonyms:
- EST182763, MRP7, SIMRP7
- Chromosome:
- 6p21.1
- Locus Type:
- gene with protein product
- Date approved:
- 1999-10-26
- Date modifiied:
- 2018-05-03
- Gene:
- ADGRA1 NIH gene
- Name:
- adhesion G protein-coupled receptor A1
- Previous symbol:
- GPR123
- Synonyms:
- KIAA1828
- Chromosome:
- 10q26.3
- Locus Type:
- gene with protein product
- Date approved:
- 2003-02-25
- Date modifiied:
- 2016-10-05
- Gene:
- ATG4B NIH gene
- Name:
- autophagy related 4B cysteine peptidase
- Previous symbol:
- APG4B
- Synonyms:
- Apg4B, KIAA0943, DKFZp586D1822, AUTL1
- Chromosome:
- 2q37.3
- Locus Type:
- gene with protein product
- Date approved:
- 2004-03-23
- Date modifiied:
- 2016-02-23
- Gene:
- ATP13A1 NIH gene
- Name:
- ATPase 13A1
- Previous symbol:
- ATP13A
- Synonyms:
- KIAA1825, FLJ31858, CGI-152
- Chromosome:
- 19p13.11
- Locus Type:
- gene with protein product
- Date approved:
- 2004-02-12
- Date modifiied:
- 2016-02-11
- Gene:
- C6orf62 NIH gene
- Name:
- chromosome 6 open reading frame 62
- Previous symbol:
- -
- Synonyms:
- FLJ12619, DKFZP564G182, XTP12
- Chromosome:
- 6p22.3
- Locus Type:
- gene with protein product
- Date approved:
- 2003-05-01
- Date modifiied:
- 2016-10-05
Related products to: TGFBI (182 aa), Recombinant protein, 10 ug.
Related articles to: TGFBI (182 aa), Recombinant protein, 10 ug.
- Pulmonary hypertension (PH) is a life-threatening cardiovascular disorder characterized by irreversible pulmonary vascular remodeling and poor prognosis. RNA pseudouridylation, the most evolutionarily conserved RNA epigenetic modification, and its catalytic enzyme pseudouridine synthase 7 (PUS7) remained uncharacterized in PH, representing a major gap in the understanding of the epigenetic pathogenesis of the disease. - Source: PubMed
Publication date: 2026/09/01
Zhang JuntingLi YiyingHe MuhuaTan JianxinChen YuanLin ZhongyuanWang HongboLiu FangChen XiaolinJia ZihuiChen HanbinChen ZhenKong FanhaoFu JiawenBian Jin-SongNie Xiao-Wei - Fuchs endothelial corneal dystrophy (FECD) involves pathological extracellular matrix (ECM) accumulation within Descemet's membrane, leading to guttae formation, endothelial dysfunction, and vision impairment. As current treatment is primarily surgical, we investigated whether Rho-associated protein kinase (ROCK) inhibition can reduce fibrotic ECM remodeling in FECD and related corneal endothelial diseases. - Source: PubMed
Schlötzer-Schrehardt UrsulaZenkel MatthiasPulasani SaiStrunz MariaGießl AndreasEkici ArifOkumura NaokiKoizumi NorikoKinoshita ShigeruTourtas TheofilosKruse Friedrich E - To report a Chinese family with lattice corneal dystrophy (LCD) caused by the TGFBI p.H626R mutation and summarize its clinical and genetic characteristics through a literature review. - Source: PubMed
Publication date: 2026/08/11
Lu XuanZhang KeLiu RubingLi ZebinTan BeilingWang HanChen ShuyiZeng Mingbing - TGFBI in tumors, providing a comprehensive theoretical foundation for developing TGFBI-based precision diagnosis and treatment. Transforming growth factor-beta-induced protein (TGFBI) is a secreted extracellular matrix protein involved in various physiological and pathological processes. Its multiple roles in tumorigenesis and the remodeling of the tumor immune microenvironment (TIME) have recently drawn increasing attention. This review systematically compares the dual pro-tumor and tumor-suppressive functions of TGFBI across multiple cancer types and provides a comprehensive analysis of its immunomodulatory roles-particularly its recently identified function as a secreted immune checkpoint bridging extracellular matrix remodeling and immune suppression. By integrating evidence from single-cell and spatial transcriptomic studies, we elucidate the cell-type-specific expression patterns of TGFBI in the tumor microenvironment and propose a tumor-type-specific therapeutic stratification framework for TGFBI-targeted interventions. This review thus fills a critical gap by providing the first systematic integration of TGFBI's context-dependent functions with its translational implications. - Source: PubMed
Publication date: 2026/07/23
Li JingwenZeng YuechengChen FengHu JinyangGuo ZhongyinPeng Peng - Jinfeng pills (JFP), a well-known traditional Chinese medicine (TCM) consisted of 9 herbs, benefit Qi, nourish the blood, effectively regulate the menstrual cycle, promote ovulation and improve endometrial thickness and blood flow. Previous studies have shown that JFP has certain effect on premature ovarian insufficiency (POI). In this prospective cohort study, the effect and mechanisms of JFP on the outcomes of in vitro fertilization and embryo transfer (IVF-ET) in poor ovarian response(POR) was investigated. - Source: PubMed
Publication date: 2026/07/18
Kong XumeiLuo QianwenHuang TianhongChen FuruiZhang YananXiong DongshengQiu YuLai WeiYan XiaoyanLong FangyiGong Yan